“The moves are meant to prepare Welch Allyn to address the new ‘onerous’ U.S. Medical Device Tax scheduled to take effect next year under the Affordable Care Act, the company said… The company can’t just pass on the tax increase to its customers — clinics, doctors’ offices and hospitals — who are already being pushed to cut costs, Chadderdon said.
The tax is 2.3 percent of a medical device maker’s U.S. revenue, but takes a bigger bite out of profits, Chief Executive Steve Meyer said Monday.”